Here, these pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) were chosen as markers to evaluate the inhibition of the inflammatory response at 24 h after cerebral ischemia and reperfusion in the hippocampus. The gene discussed is IL1B; the disease is Cerebral ischemia.